Zingo assets sold

December 13, 2009

Email this news item to a friend/colleague Email this news item to a friend/colleague

zingo

Intravenous products: PR-Canada.net report “Anesiva, Inc. announced today that on December 3, 2009, Anesiva entered into an Asset Purchase Agreement which assigned its rights under the Revised License Agreement with PowderJect Technologies, Ltd., dated November 30, 2009, and sold certain assets related to Zingo to Powder Pharmaceuticals, Inc. (Powder Pharma), a British Virgin Island LLC, and Lee’s Pharmaceuticals (HK) Limited (Lee’s Pharma), a British Virgin Island LLC. Under the terms of the Asset Purchase Agreement, the total purchase price of the Zingo-related assets was approximately $2.7 million with payment contingent on the delivery of certain assets to Powder Pharma and Lee’s Pharma.
Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system, is an easy-to-administer, single-use, needle-free system that reduces the pain associated with peripheral intravenous (IV) line placements and blood draws in children three to 18 years of age and with blood draws for adults.”

Click here for the full story.


Other stories

Written by IVTEAM · Filed Under All, IV Products 

Add IVTEAM to Technorati Favorites del.icio.us:Zingo assets sold digg:Zingo assets sold spurl:Zingo assets sold wists:Zingo assets sold simpy:Zingo assets sold newsvine:Zingo assets sold blinklist:Zingo assets sold furl:Zingo assets sold reddit:Zingo assets sold fark:Zingo assets sold blogmarks:Zingo assets sold Y!:Zingo assets sold smarking:Zingo assets sold magnolia:Zingo assets sold segnalo:Zingo assets sold gifttagging:Zingo assets sold

Comments

Comments are closed.